World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN34049135
Date of registration: 30/10/2006
Prospective Registration: No
Primary sponsor: Gambro Industries (France)
Public title: Prospective pilot study: evaluation of a new dressing for patients treated in peritoneal dialysis
Scientific title:
Date of first enrolment: 25/09/2006
Target sample size: 20
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN34049135
Study type:  Observational
Study design:  Monocentric, open, comparative study (Treatment)  
Phase: 
Countries of recruitment
France
Contacts
Name: Robert    Milongo
Address:  AGDUC Hôpital La Tronche 38 700 Grenoble France
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Patients with well healed exit site
2. Patients treated for at least three months in peritoneal dialysis irrespective of the treatment mode
3. Patients with healthy skin judged by investigator
4. Patients aged 18 years and older
5. Patients having signed a written consent (informed consent) to participate in the study

Exclusion criteria: 1. Patients treated in hemodialysis
2. Patients with diagnosed abdominal pain not related with PD-solution
3. Peritonitis within one month prior to the study
4. Presence of exit-site, tunnel infection
5. Patients with ongoing peritonitis
6. Patients participating in other studies during the period of this study
7. Patients practising swimming
8. Patients under guardianship
9. Pregnancy, lactation


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Chronic renal failure
Urological and Genital Diseases
Chronic renal failure
Intervention(s)
Evaluation of dressing advantages via questionnaires
Primary Outcome(s)
Dressing advantages are evaluated via questionnaires, which have to be filled in at specific time schedule. Comfort and safety evaluation will be performed by the patient at the end of each period of product use (end of PD Immo use and end of usual dressing use).
Secondary Outcome(s)
Handling is also evaluated via the patient questionnaire.
The incidence of Adverse Events (AE) will be followed during the study period.
Secondary ID(s)
1445
Source(s) of Monetary Support
Gambro Industries (France)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history